Diabetes treatment is constantly evolving, with new therapeutic options emerging to improve patient outcomes. Recent investigations have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the https://lexiezlqr138261.aioblogs.com/91708410/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment